ENTRY       D00978                      Drug
NAME        Hydrocortisone sodium succinate (JP18/USP);
            A-hydrocort (TN);
            Solu-cortef (TN)
PRODUCT     SOLU-CORTEF (Cardinal Health 107)
            SOLU-CORTEF (HF Acquisition Co. LLC)
            SOLU-CORTEF (HF Acquisition Co. LLC)
            SOLU-CORTEF (Pharmacia & Upjohn Company LLC)
FORMULA     C25H33O8. Na
EXACT_MASS  484.2073
MOL_WEIGHT  484.5145
CLASS       Anti-inflammatory
             DG01955  Corticosteroid
              DG02068  Glucocorticoid
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      Same as: C08178
            Therapeutic category: 2452
            ATC code: A01AC03 A07EA02 C05AA01 D07AA02 D07XA01 H02AB09 S01BA02 S01CB03 S02BA01
            Chemical structure group: DG00012
            Product (DG00012): D00088<JP/US> D00165<US> D00977<JP> D00978<JP/US> D01619<JP/US> D01886<JP/US> D02288<US>
EFFICACY    Anti-inflammatory, Glucocorticoid receptor agonist
  DISEASE   Asthma [DS:H00079]
            Atopic dermatitis [DS:H01358]
            Contact dermatitis [DS:H01357]
            Perennial or seasonal allergic rhinitis [DS:H01360]
            Bullous dermatitis herpetiformis [DS:H01362]
            Mycosis fungoides [DS:H01463]
            Pemphigus [DS:H01648]
            Severe erythema multiforme [DS:H01695]
            Stevens-Johnson syndrome [DS:H01694]
            Ulcerative colitis [DS:H01466]
            Acquired (autoimmune) hemolytic anemia [DS:H01585]
            Diamond-Blackfan anemia [DS:H00237]
            Pure red cell aplasia [DS:H01586]
            Multiple sclerosis [DS:H01490]
            Nephrotic syndrome [DS:H01657]
            Pulmonary tuberculosis [DS:H00342]
            Ankylosing spondylitis [DS:H01674]
            Psoriatic arthritis [DS:H01507]
            Rheumatoid arthritis [DS:H00630]
            Juvenile rheumatoid arthritis [DS:H01672]
            Dermatomyositis [DS:H01604]
            Temporal arteritis [DS:H01698]
            Polymyositis [DS:H01604]
            Systemic lupus erythematosus [DS:H00080]
TARGET      NR3C1 (GR) [HSA:2908] [KO:K05771]
  PATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION  
STR_MAP     map07225  Glucocorticoid and mineralocorticoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AC Corticosteroids for local oral treatment
                 A01AC03 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
              A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
               A07E INTESTINAL ANTIINFLAMMATORY AGENTS
                A07EA Corticosteroids acting locally
                 A07EA02 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
             C CARDIOVASCULAR SYSTEM
              C05 VASOPROTECTIVES
               C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
                C05AA Corticosteroids
                 C05AA01 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
             D DERMATOLOGICALS
              D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
               D07A CORTICOSTEROIDS, PLAIN
                D07AA Corticosteroids, weak (group I)
                 D07AA02 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
               D07X CORTICOSTEROIDS, OTHER COMBINATIONS
                D07XA Corticosteroids, weak, other combinations
                 D07XA01 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H02 CORTICOSTEROIDS FOR SYSTEMIC USE
               H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
                H02AB Glucocorticoids
                 H02AB09 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01B ANTIINFLAMMATORY AGENTS
                S01BA Corticosteroids, plain
                 S01BA02 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
               S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
                S01CB Corticosteroids/antiinfectives/mydriatics in combination
                 S01CB03 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
              S02 OTOLOGICALS
               S02B CORTICOSTEROIDS
                S02BA Corticosteroids
                 S02BA01 Hydrocortisone
                  D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
              Hydrocortisone
               D00978  Hydrocortisone sodium succinate (JP18/USP)
             Inflammatory Bowel Disease Agents
              Glucocorticoids
               Hydrocortisone
                D00978  Hydrocortisone sodium succinate (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               245  Adrenal hormone preparations
                2452  Cortisones
                 D00978  Hydrocortisone sodium succinate (JP18/USP)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00012  Hydrocortisone
                 D00978  Hydrocortisone sodium succinate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00978  Hydrocortisone sodium succinate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG00012  Hydrocortisone
                D00978  Hydrocortisone sodium succinate
            Drug classes [BR:br08332]
             Anti-inflammatory
              DG01955  Corticosteroid
               D00978  Hydrocortisone sodium succinate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00978  Hydrocortisone sodium succinate
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                NR3C1 (GR)
                 D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00978  Hydrocortisone sodium succinate
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00978
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00012  Hydrocortisone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG00012  Hydrocortisone
DBLINKS     CAS: 125-04-2
            PubChem: 7848041
            ChEBI: 5782
            LigandBox: D00978
            NIKKAJI: J5.365A
ATOM        34
            1   C1z C    20.9235  -16.1233
            2   C1y C    20.9409  -17.4723
            3   C1z C    22.0855  -15.4342
            4   C1x C    19.7729  -15.4518
            5   C1a C    20.9231  -14.8152
            6   C1y C    19.7846  -18.1554
            7   C1x C    23.2184  -17.5247
            8   C1x C    23.2710  -16.0999
            9   C5a C    22.1496  -13.8520
            10  O1a O    23.4403  -15.0020
            11  C1y C    18.5875  -16.1349
            12  C1y C    18.5935  -17.4840
            13  C1x C    19.7846  -19.5044
            14  C1b C    23.3877  -13.1980
            15  O5a O    20.9351  -13.1512
            16  O1a O    17.3613  -15.4401
            17  C1z C    17.4431  -18.1613
            18  C1x C    18.6109  -20.1935
            19  O7a O    24.5848  -13.9512
            20  C2y C    17.4548  -19.5161
            21  C1x C    16.2577  -17.4956
            22  C1a C    17.4310  -16.8708
            23  C7a C    25.7994  -13.2505
            24  C2x C    16.2693  -20.2109
            25  C1x C    15.0839  -18.1730
            26  C1b C    27.0082  -13.9512
            27  O6a O    25.7877  -11.8373
            28  C5x C    15.0605  -19.6037
            29  C1b C    28.2170  -13.2505
            30  O5x O    13.8751  -20.2402
            31  C6a C    29.4141  -13.9512
            32  O6a O    29.4081  -15.3351
            33  O6a O    30.5761  -13.1980 #-
            34  Z   Na   33.3791  -13.5130 #+
BOND        36
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1 #Up
            5     2   6 1
            6     2   7 1
            7     3   8 1
            8     3   9 1 #Up
            9     3  10 1 #Down
            10    4  11 1
            11    6  12 1
            12    6  13 1
            13    9  14 1
            14    9  15 2
            15   11  16 1 #Up
            16   12  17 1
            17   13  18 1
            18   14  19 1
            19   17  20 1
            20   17  21 1
            21   17  22 1 #Up
            22   19  23 1
            23   20  24 2
            24   21  25 1
            25   23  26 1
            26   23  27 2
            27   24  28 1
            28   26  29 1
            29   28  30 2
            30   29  31 1
            31   31  32 2
            32   31  33 1
            33    7   8 1
            34   11  12 1
            35   18  20 1
            36   25  28 1
///
